Impact of comprehensive hospice palliative care on end-of-life care: a propensity-score-matched retrospective observational study.
Journal
CMAJ open
ISSN: 2291-0026
Titre abrégé: CMAJ Open
Pays: Canada
ID NLM: 101620603
Informations de publication
Date de publication:
Historique:
entrez:
6
4
2019
pubmed:
6
4
2019
medline:
6
4
2019
Statut:
epublish
Résumé
Access to hospice palliative care may improve quality of life, reduce the use of potentially aggressive end-of-life care and allow for death to occur outside of an acute care hospital. The aim of this study was to examine the impact of an ambulatory hospice palliative care program on end-of-life care compared to care received by a matched control group of deceased patients. This retrospective study included patients who received hospice palliative care through the Symptom Management Program in Sudbury, Ontario, during 2012-2015. Using linked administrative health records, we defined a propensity-matched control group and derived 4 previously defined variables associated with aggressive end-of-life care (chemotherapy received in the last 2 wk of life, > 1 emergency department visit within 30 d of death, > 1 hospital admission within 30 d of death and at least 1 intensive care unit admission within 30 d of death). We also examined place of death. We measured family/caregiver satisfaction with care 3 months after the patient's death using the FAMCARE questionnaire. Of 914 eligible decedents enrolled in the Symptom Management Program, 754 (82.5%) were matched. Receiving care through the program was protective for most measures of aggressive end-of-life care (absolute risk reduction [ARR] 12.73, 95% confidence interval [CI] 12.65-12.81 for any end-of-life care outcome) and death in an acute care setting (ARR 19.89, 95% CI 19.78-20.00). Of the 450 family caregivers invited to complete the FAMCARE questionnaire, 190 (42.2%) returned completed surveys; following data linkage and matching, 96 (21.3%) were available for analysis. Satisfaction with care received within the program appeared high (mean total score 85.72/100). Provision of hospice palliative care through this ambulatory program was associated with lower use of aggressive end-of-life care and death outside of an acute care hospital. Improving access could be expected to provide positive benefits at the individual and system level.
Sections du résumé
BACKGROUND
BACKGROUND
Access to hospice palliative care may improve quality of life, reduce the use of potentially aggressive end-of-life care and allow for death to occur outside of an acute care hospital. The aim of this study was to examine the impact of an ambulatory hospice palliative care program on end-of-life care compared to care received by a matched control group of deceased patients.
METHODS
METHODS
This retrospective study included patients who received hospice palliative care through the Symptom Management Program in Sudbury, Ontario, during 2012-2015. Using linked administrative health records, we defined a propensity-matched control group and derived 4 previously defined variables associated with aggressive end-of-life care (chemotherapy received in the last 2 wk of life, > 1 emergency department visit within 30 d of death, > 1 hospital admission within 30 d of death and at least 1 intensive care unit admission within 30 d of death). We also examined place of death. We measured family/caregiver satisfaction with care 3 months after the patient's death using the FAMCARE questionnaire.
RESULTS
RESULTS
Of 914 eligible decedents enrolled in the Symptom Management Program, 754 (82.5%) were matched. Receiving care through the program was protective for most measures of aggressive end-of-life care (absolute risk reduction [ARR] 12.73, 95% confidence interval [CI] 12.65-12.81 for any end-of-life care outcome) and death in an acute care setting (ARR 19.89, 95% CI 19.78-20.00). Of the 450 family caregivers invited to complete the FAMCARE questionnaire, 190 (42.2%) returned completed surveys; following data linkage and matching, 96 (21.3%) were available for analysis. Satisfaction with care received within the program appeared high (mean total score 85.72/100).
INTERPRETATION
CONCLUSIONS
Provision of hospice palliative care through this ambulatory program was associated with lower use of aggressive end-of-life care and death outside of an acute care hospital. Improving access could be expected to provide positive benefits at the individual and system level.
Identifiants
pubmed: 30948648
pii: 7/2/E197
doi: 10.9778/cmajo.20180148
pmc: PMC6450796
doi:
Types de publication
Journal Article
Langues
eng
Pagination
E197-E202Informations de copyright
Copyright 2019, Joule Inc. or its licensors.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Clin Oncol. 2003 Mar 15;21(6):1133-8
pubmed: 12637481
Palliat Med. 2006 Dec;20(8):769-77
pubmed: 17148531
Palliat Support Care. 2010 Jun;8(2):169-76
pubmed: 20331914
Support Care Cancer. 2011 Apr;19(4):565-72
pubmed: 20349317
Cancer J. 2010 Sep-Oct;16(5):423-35
pubmed: 20890138
Pharm Stat. 2011 Mar-Apr;10(2):150-61
pubmed: 20925139
Stat Med. 2011 May 20;30(11):1292-301
pubmed: 21337595
J Clin Oncol. 2011 Apr 20;29(12):1587-91
pubmed: 21402603
J Support Oncol. 2011 May-Jun;9(3):87-94
pubmed: 21702398
Qual Life Res. 2013 Nov;22(9):2341-9
pubmed: 23435667
CMAJ. 2013 Jul 9;185(10):E451-2
pubmed: 23713070
Stat Med. 2014 Mar 15;33(6):1057-69
pubmed: 24123228
Cancer. 2015 Sep 15;121(18):3307-15
pubmed: 26031241
CMAJ. 2016 Feb 16;188(3):182-188
pubmed: 26755672
JAMA. 2016 Jan 19;315(3):284-92
pubmed: 26784776
Future Oncol. 2016 Mar;12(6):807-13
pubmed: 26837318
Am Soc Clin Oncol Educ Book. 2016;35:e534-8
pubmed: 27249764
Curr Opin Support Palliat Care. 2016 Dec;10(4):310-315
pubmed: 27635766
Ann Oncol. 2017 Jan 1;28(1):163-168
pubmed: 27687308
Palliat Med. 2017 Apr;31(4):378-386
pubmed: 28156192
Curr Oncol. 2017 Aug;24(4):256-261
pubmed: 28874894
Soc Sci Med. 1993 Mar;36(5):693-701
pubmed: 8456339